Corrigendum: Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)

• John A. Rudd,
• John A. Rudd,
• Sze W. Chan,
• Man P. Ngan,
• Longlong Tu,
• Zengbing Lu,
• Claudio Giuliano,
• Emanuela Lovati,
• Claudio Pietra

Affiliations

John A. Rudd

Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

John A. Rudd

Brain and Mind Institute, The Chinese University of Hong Kong, Shatin, Hong Kong

Sze W. Chan

School of Health Sciences, Caritas Institute of Higher Education, Tseung Kwan O New Town, Hong Kong

Man P. Ngan

Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

Longlong Tu

Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

Zengbing Lu

Emesis Research Group, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

Claudio Giuliano

Helsinn Healthcare SA, Research and Development, Lugano, Switzerland

Emanuela Lovati

Helsinn Healthcare SA, Research and Development, Lugano, Switzerland

Claudio Pietra

Helsinn Healthcare SA, Research and Development, Lugano, Switzerland